Personalized Nanomedicines for Leukemia Patients

Jun J Yang

ARID5B and Disparities of Childhood Leukemia

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Ravindra Majeti

Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML

Leukaemia

Hematology and hematologic malignancies

Xiaoyan Jiang

Molecular Targeting of Critical Domains of AHI-1 Oncoprotein in Chronic Myeloid Leukemia Stem Cells Resistant to Current Tyrosine Kinase Inhibitor Therapy

Leukaemia

Katy Rezvani

Curative Cell-based Therapies for Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Investigator from BioInvent (Sweden)

Clinical validation of the CD32b biomarker on the European market

Leukaemia

Pathology

Investigator from University of Freiburg

Hematopoietic stem cell Apoptosis in bone marrow failure and MyeloDysplastic Syndromes: Friend or foe?

Leukaemia

Christopher S Carlson

Impact of primary tumor development stage on prognosis and outcome in B-ALL

Leukaemia

Pediatric oncology or childhood cancer

Bruce R Blazar

Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)

Leukaemia

Hematology and hematologic malignancies Pathology

Kimberly Stegmaier

Validating Syk as a Target for AML Therapy

Leukaemia